Ash Stevens, Inc. Founded in 1962, Ash Stevens, Inc. (ASI) offers comprehensive small-molecule drug development and manufacturing services spanning early-stage development through FDA registration, and commercial API manufacturing. ASI has a long and successful history (over forty-nine years) of working with Life Science companies of all sizes to help translate their early-stage development candidates to commercial realities. In addition to ASI's major business focus of providing contract drug development and manufacturing services to commercial clients, the company is also a long-time research contractor to the Federal Government (NIH and NCI) and has worked on many of the drugs developed through these agencies. To date, Ash Stevens has achieved an impressive track record of eleven FDA approvals for innovator APIs.